The clinical utility of the local inflammatory response in colorectal cancer

European Journal of Cancer

Volumn 50, Issue 2, 2014, Pages 309-319

  Richards, Colin H ^a   Roxburgh, Campbell S D ^a   Powell, Arfon G ^a   Foulis, Alan K ^b   Horgan, Paul G ^a   McMillan, Donald C ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Colorectal cancer; Host response; Inflammation; Lymphocytes; Malignancy; Outcome; Prognosis; Survival

Indexed keywords

CD45RO ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVOR; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLORECTAL CANCER; FEMALE; FOLLOW UP; GALON IMMUNE SCORE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KLINTRUP MAKINEN GRADE; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; SCORING SYSTEM; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION;

EID: 84891827303     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.09.008     Document Type: Article

References (36)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 12 2010 2893 2917
2. Cancerstats; 2008. Available from: http://www.cancerresearchuk.org [cited 2010 September 1st].
3. C.C. Compton, L.P. Fielding, L.J. Burgart, B. Conley, H.S. Cooper, and S.R. Hamilton et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 7 2000 979 994
4. B. Mlecnik, G. Bindea, F. Pages, and J. Galon Tumor immunosurveillance in human cancers Cancer Metastasis Rev 30 1 2011 5 12
5. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 2011 646 674
6. C.S. Roxburgh, and D.C. McMillan The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer Cancer Treat Rev 38 5 2012 451 466
7. J. Galon, F. Pages, F.M. Marincola, M. Thurin, G. Trinchieri, and B.A. Fox et al. The immune score as a new possible approach for the classification of cancer J Transl Med 10 2012 1
8. J.W. Huh, J.H. Lee, and H.R. Kim Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer Arch Surg 147 4 2012 366 372
9. D.J. Hole, and C.S. McArdle Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer Br J Surg 89 5 2002 586 590
10. G.P. Copeland, D. Jones, and M. Walters POSSUM: a scoring system for surgical audit Br J Surg 78 3 1991 355 360
11. M. Maltoni, A. Caraceni, C. Brunelli, B. Broeckaert, N. Christakis, and S. Eychmueller et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care J Clin Oncol 23 25 2005 6240 6248
12. S.R. Walsh, E.J. Cook, F. Goulder, T.A. Justin, and N.J. Keeling Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol 91 3 2005 181 184
13. D.C. McMillan An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer Proc Nutr Soc 67 3 2008 257 262
14. I.D. Fleming, J.S. Cooper, D.E. Henson, R.V.P. Hutter, B.J. Kennedy, and G.P. Murphy et al. AJCC 5th edition cancer staging manual 1997 Lippincott-Raven Philadelphia
15. M.J. Pollheimer, P. Kornprat, R.A. Lindtner, L. Harbaum, A. Schlemmer, and P. Rehak et al. Tumor necrosis is a new promising prognostic factor in colorectal cancer Hum Pathol 41 12 2010 1749 1757
16. B. Mlecnik, M. Tosolini, A. Kirilovsky, A. Berger, G. Bindea, and T. Meatchi et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction J Clin Oncol 29 6 2011 610 618
17. K. Klintrup, J.M. Makinen, S. Kauppila, P.O. Vare, J. Melkko, and H. Tuominen et al. Inflammation and prognosis in colorectal cancer Eur J Cancer 41 17 2005 2645 2654
18. C.S. Roxburgh, J.M. Salmond, P.G. Horgan, K.A. Oien, and D.C. McMillan Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer Eur J Cancer 45 12 2009 2138 2145
19. C.H. Richards, K.M. Flegg, C.S. Roxburgh, J.J. Going, Z. Mohammed, and P.G. Horgan et al. The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer Br J Cancer 106 12 2012 2010 2015
20. H.J. Nielsen, U. Hansen, I.J. Christensen, C.M. Reimert, N. Brunner, and F. Moesgaard Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue J Pathol 189 4 1999 487 495
21. Y. Naito, K. Saito, K. Shiiba, A. Ohuchi, K. Saigenji, and H. Nagura et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res 58 16 1998 3491 3494
22. J. Galon, A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, and C. Lagorce-Pages et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 5795 2006 1960 1964
23. F. Pages, A. Berger, M. Camus, F. Sanchez-Cabo, A. Costes, and R. Molidor et al. Effector memory T cells, early metastasis, and survival in colorectal cancer N Engl J Med 353 25 2005 2654 2666
24. P. Salama, M. Phillips, F. Grieu, M. Morris, N. Zeps, and D. Joseph et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer J Clin Oncol 27 2 2009 186 192
25. I.D. Nagtegaal, C.A. Marijnen, E.K. Kranenbarg, A. Mulder-Stapel, J. Hermans, and C.J. van de Velde et al. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study BMC Cancer 1 2001 7
26. A.C. Diederichsen, J.B. Hjelmborg, P.B. Christensen, J. Zeuthen, and C. Fenger Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells Cancer Immunol Immunother 52 7 2003 423 428
27. K. Hase, C. Shatney, D. Johnson, M. Trollope, and M. Vierra Prognostic value of tumor "budding" in patients with colorectal cancer Dis Colon Rectum 36 7 1993 627 635
28. H. Kanazawa, H. Mitomi, Y. Nishiyama, I. Kishimoto, N. Fukui, and T. Nakamura et al. Tumour budding at invasive margins and outcome in colorectal cancer Colorectal Dis 10 1 2008 41 47
29. J.R. Jass, S.B. Love, and J.M. Northover A new prognostic classification of rectal cancer Lancet 1 8545 1987 1303 1306
30. T.L. Whiteside The tumor microenvironment and its role in promoting tumor growth Oncogene [Research Support, N.I.H., Extramural Review] 27 45 2008 5904 5912
31. G.P. Dunn, L.J. Old, and R.D. Schreiber The immunobiology of cancer immunosurveillance and immunoediting Immunity 21 2 2004 137 148
32. S. Ferrone, and T.L. Whiteside Tumor microenvironment and immune escape Surg Oncol Clin North Am [Research Support, N.I.H., Extramural Review] 16 4 2007 755 774 viii
33. F. Balkwill, and L.M. Coussens Cancer: an inflammatory link Nature 431 7007 2004 405 406 [News]
34. G. Guthrie, and D.C. McMillan Comment on 'Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma' Br J Cancer 108 9 2013 1915 1916 [Letter]
35. M.A. Jenkins, S. Hayashi, A.M. O'Shea, L.J. Burgart, T.C. Smyrk, and D. Shimizu et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study Gastroenterology 133 1 2007 48 56
36. S. Ogino, K. Nosho, N. Irahara, J.A. Meyerhardt, Y. Baba, and K. Shima et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype Clin Cancer Res 15 20 2009 6412 6420